BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35811052)

  • 1. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
    Novak B; Heesen L; Schary N; Lübbert H
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
    Nakanishi T; Ogawa T; Yanagihara C; Tamai I
    J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
    Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells.
    Omura N; Nonoguchi N; Fujishiro T; Park Y; Ikeda N; Kajimoto Y; Hosomi R; Yagi R; Hiramatsu R; Furuse M; Kawabata S; Fukunaga K; Kuroiwa T; Nakano I; Wanibuchi M
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103119. PubMed ID: 36336324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
    Anand S; Honari G; Hasan T; Elson P; Maytin EV
    Clin Cancer Res; 2009 May; 15(10):3333-43. PubMed ID: 19447864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy.
    Mikolajewska P; Juzeniene A; Moan J
    Transl Res; 2008 Sep; 152(3):128-33. PubMed ID: 18774542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
    Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
    Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
    J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.